Meningitis B Vaccine Fails to Protect Against Gonorrhea in Trial

(MedPage Today) — DENVER — The four-component meningococcal serogroup B vaccine (4CMenB; Bexsero) did not reduce gonorrhea incidence in high-risk men who have sex with men, according to a randomized trial.
The incidence rate ratio [IRR] of…

Source link : https://www.medpagetoday.com/meetingcoverage/croi/120070

Author :

Publish date : 2026-02-26 22:16:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Meningitis B Vaccine Fails to Protect Against Gonorrhea in Trial

Better Survival in Refractory CRC With Chemo Plus Bevacizumab, Real-World Study Says

Related Posts

Better Survival in Refractory CRC With Chemo Plus Bevacizumab, Real-World Study Says

The ‘Love Is Blind’ Physician; Blizzard vs Pediatrician; America’s Next Top RN

Novel GLP-1 Pill Tops Oral Semaglutide for Diabetes

Trump Admin to Pause Medicaid Funding to Minnesota Because of Fraud Concerns

Maternity Services ‘Still Failing’ Women and Babies

Very Early ART Initiation in Children With HIV Could Lead to ART-Free Remission

Meningitis B Vaccine Fails to Protect Against Gonorrhea in Trial

Better Survival in Refractory CRC With Chemo Plus Bevacizumab, Real-World Study Says

The ‘Love Is Blind’ Physician; Blizzard vs Pediatrician; America’s Next Top RN

Novel GLP-1 Pill Tops Oral Semaglutide for Diabetes

Trump Admin to Pause Medicaid Funding to Minnesota Because of Fraud Concerns

Maternity Services ‘Still Failing’ Women and Babies

Very Early ART Initiation in Children With HIV Could Lead to ART-Free Remission

When we interbred with Neanderthals, they were usually the fathers

Categories

Archives